Medications

Alzheimer's drug trial shows 'evidence of sustained improvement'

Almost four decades ago the University of Aberdeen's Chair in Mental Health (Clinical), Professor Claude Wischik, made a breakthrough in discovering that the neurofibrillary "tangles" associated with Alzheimer's disease were ...

Neuroscience

Type 2 diabetes accelerates brain aging and cognitive decline

Scientists have demonstrated that normal brain aging is accelerated by approximately 26% in people with progressive type 2 diabetes compared to individuals without the disease, reports a study published today in eLife.

Neuroscience

Hit the sleep 'sweet spot' to keep brain sharp

Like so many other good things in life, sleep is best in moderation. A multiyear study of older adults found that both short and long sleepers experienced greater cognitive decline than people who slept a moderate amount, ...

Alzheimer's disease & dementia

Metformin treatment linked to slowed cognitive decline

Metformin is the first-line treatment for most cases of type 2 diabetes and one of the most commonly prescribed medications worldwide, with millions of individuals using it to optimize their blood glucose levels.

page 2 from 32